|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Predictors of suboptimal bowel preparation in asymptomatic patients undergoing average-risk screening colonoscopy显示文摘AIM To identify risk factors for a suboptimal preparation among a population undergoing screening or surveillance colonoscopy.METHODS Retrospective review of the University of Michigan and Veteran's Administration(VA) Hospital records from 2009 to identify patients age 50 and older who underwent screening or surveillance procedure and had resection of polyps less than 1 cm in size and no more than 2 polyps. Patients with inflammatory bowel disease or a family history of colorectal cancer were excluded. Suboptimal procedures were defined as procedure preparations categorized as fair, poor or inadequate by the endoscopist. Multivariable logistic regression was used to identify predictors of suboptimal preparation.RESULTS Of 4427 colonoscopies reviewed, 2401 met our inclusion criteria and were analyzed. Of our population, 16% had a suboptimal preparation. African Americans were 70% more likely to have a suboptimal preparation(95%CI: 1.2-2.4). Univariable analysis revealed that narcotic and tricyclic antidepressants(TCA) use, diabetes, prep type, site(VA vs non-VA), and presence of a gastroenterology(GI) fellow were associated with suboptimal prep quality. In a multivariable model controlling for gender, age, ethnicity, procedure site and presence of a GI fellow, diabetes [odds ratio(OR) = 2.3; 95%CI: 1.6-3.2], TCA use(OR = 2.5; 95%CI: 1.3-4.9), narcotic use(OR = 1.7; 95%CI: 1.2-2.5) and Miralax-Gatorade prep vs 4L polyethylene glycol 3350(OR = 0.6; 95%CI: 0.4-0.9) were associated with a suboptimal prep quality. CONCLUSION Diabetes, narcotics use and TCA use were identified as predictors of poor preparation in screening colonoscopies while Miralax-Gatorade preps were associated with better bowel preparation. | Shail M Govani Eric E Elliott Stacy B Menees Stephanie L Judd Sameer D Saini Constantinos P Anastassiades Annette L Urganus Suzanna J Boyce Philip S Schoenfeld | 2016 | World Journal of Gastrointestinal Endoscopy2016，8，17： | 7 |
| 2 | Production of hepatic outflow block and ascites with an ameroid constrictor 显示文摘 | Sweat E R Musieant M E Annetts D L | 1966 | Surg Forum1966，17，： | 1 |
| 3 | Integrating Point-to-Point Videoconfer- encing into Professional Development of Rural Elementary School Science Teachers 显示文摘 | L Annette D Dickerson | 2006 | Contemporary Issues in Technology and Teacher Education2006，，4： | 1 |
| 4 | Acquiring new knowledge: The role of retaining human capital in acquisitions of high teeh firms 显示文摘 | Annette L L Michael D | 2000 | Journal of High Technology Management Research2000，11，2： | 1 |
| 5 | Ginkgo biloba for prevention of dementia a randomized controlled trial显示文摘 | Steven T Jeff D Annette L | 2008 | JAMA2008，300，19： | 1 |
| 6 | Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein : a new primate model of Parkinson's disease 显示文摘 | KIRIK D ANNETT L E BURGER C | 2003 | Proc Natl Acad Sci U S A2003，100，28： | 1 |
| 7 | Acquiring new technologies and capabilities:A grounded model of acquisition implementation显示文摘 | ANNETTE L RANFT MICHAEL D LORD | 2002 | Organization Science2002，13，4： | 1 |
| 8 | Nigrostriatal alpha-synucleinopathyinduced by viral vector-mediated overexpression of human alpha-synuclein:A new primate model of Parkinson's disease显示文摘 | Kirik D Annett L E Burger C | 2002 | Proc Natl Acad Sci USA2002，100，5： | 1 |
| 9 | Inner city stormwater con- trol using a combination of best management practices 显示文摘 | Villarreal E L Annette S D | 2004 | Ecol Eng2004，22，4： | 1 |
| 10 | New lipid formulation of am- photericin B:spectral and microscopic analysis 显示文摘 | Malika L Annette G Jean -Paul D | 2004 | Biochim Biophys Ac- ta2004，1664，： | 1 |
| 11 | Acquiring new technologies and capabilities: a grounded model of acquisition implementation 显示文摘 | ANNETTE L RANFT Lord M D | 2002 | Organization Science2002，13，4： | 1 |
| 12 | Rolling-circle amplification for the detection of active porcine circovirus type 2 DNA replication in vitro显示文摘 | Paolo D N Hao L Annette M | 2008 | J Virol Methods2008，152，12： | 1 |
| 13 | Acquiring new technologies and capabilities : a grounded model of acquisition implementation 显示文摘 | Annette L Ranft Lord M D | 2002 | Organization Science2002，13，4： | 1 |
| 14 | An international survey of classification and treatment choices for group D retinoblastoma显示文摘AIM: To determine which IIRC scheme was used by retinoblastoma centers worldwide and the percentage of D eyes treated primarily with enucleation versus globe salvaging therapies as well as to correlate trends in treatment choice to IIRC version used and geographic region.METHODS: An anonymized electronic survey was offered to 115 physicians at 39 retinoblastoma centers worldwide asking about IIRC classification schemes and treatment patterns used between 2008 and 2012. Participants were asked to record which version of the IIRC was used for classification, how many group D eyes were diagnosed, and how many eyes were treated with enucleation versus globe salvaging therapies. Averages of eyes per treatment modality were calculated and stratified by both IIRC version and geographic region. Statistical significance was determined by Chi-square, ANOVA and Kruskal-Wallis tests using Prism.RESULTS: The survey was completed by 29% of physicians invited to participate. Totally 1807 D eyes were diagnosed. Regarding IIRC system, 27% of centers used the Children's Hospital of Los Angeles(CHLA) version, 33% used the Children's Oncology Group(COG) version, 23% used the Philadelphia version, and 17% were unsure. The rate for primary enucleation varied between 0 and 100% and the mean was 29%. By IIRC version, primary enucleation rates were: Philadelphia, 8%; COG, 34%; and CHLA, 37%. By geographic region, primary enucleation rates were: Latin America, 57%; Asia, 40%; Europe, 36%; Africa, 10%, US, 8%; and Middle East, 8%. However, systemic chemoreduction was used more often than enucleation in all regions except Latin America with a mean of 57% per center(P<0.0001). CONCLUSION: Worldwide there is no consensus on which IIRC version is used, systemic chemoreduction was the most frequently used initial treatment during the study period followed by enucleation and primary treatment modality, especially enucleation, varied greatly with regards to IIRC version used and geographic region. | Christina Scelfo Jasmine H Francis Vikas Khetan Thomas Jenkins Brian Marr David H Abramson Carol L Shields Jacob Pe’er Francis Munier Jesse Berry J.William Harbour Andrey Yarovoy Evandro Lucena Timothy G Murray Pooja Bhagia Evelyn Paysse Samuray Tuncer Guillermo L Chantada Annette C Moll Tatiana Ushakova David A Plager Islamov Ziyovuddin Carlos A Leal Miguel A Materin Xun-Da Ji Jose W Cursino Rodrigo Polania Hayyam Kiratli Charlotta All-Ericsson Rejin Kebudi Santosh G Honavar Vicktoria Vishnevskia-Dai Sidnel Epelman Anthony B Daniels Jeanie D Ling Fousseyni Traore Marco A Ramirez-Ortiz | 2017 | International Journal of Ophthalmology(English edition)2017，10，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员